Pharmacokinetics of p53 fusion protein

被引：0

作者：

Xie, Li-xin ^{[1
]}

Wang, Wan-ling ^{[1
]}

Zhang, Hui ^{[1
]}

Fang, Fang ^{[1
]}

Fang, Yun-xiang ^{[1
]}

机构：

[1] Cent S Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha 410078, Peoples R China

来源：

ACTA PHARMACOLOGICA SINICA | 2006年 / 27卷

关键词：

p53 fusion protein; pharmacokinetics;

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

页码：219 / 219

页数：1

共 50 条

[31] The problems of radiobiology and p53 protein
Mazurik, V.K.
Moroz, B.B.
Radiatsionnaya Biologiya. Radioekologiya, 2001, 41 (05): : 548 - 572
[32] The Transactivation Domains of the p53 Protein
Raj, Nitin
Attardi, Laura D.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2017, 7 (01):
[33] Exonucleolytic proofreading by p53 protein
Bakhanashvili, M
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (07): : 2047 - 2054
[34] THE ABERRANT P53 PROTEIN (REVIEW)
FURIHATA, M
SONOBE, H
OHTSUKI, Y
INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 6 (06) : 1209 - 1226
[35] Expression of p53 protein in psoriasis
Baran, W.
Szepietowski, J. C.
Szybejko-Machaj, G.
ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2005, 14 (03): : 79 - 83
[36] The p53 tumour suppressor protein
Hickman, E.S.
Helin, K.
Biotechnology and Genetic Engineering Reviews, 2000, 17 : 179 - 211
[37] P53 PROTEIN EXPRESSION IN LEUKEMIAS
PAYDAS, S
ACTA ONCOLOGICA, 1995, 34 (01) : 23 - 26
[38] DETECTION OF P53 PROTEIN IN GLIOMAS
BRUNER, JM
MOSER, RP
SAYA, H
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1990, 49 (03): : 323 - 323
[39] FAK and p53 Protein Interactions
Golubovskaya, Vita M.
Cance, William G.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2011, 11 (07) : 617 - 619
[40] p53 autoantibodies in sera of breast cancer patients: Association with p53 gene mutations and p53 protein overexpression.
Angelopoulou, K
Yu, H
Diamandis, EP
CLINICAL CHEMISTRY, 1997, 43 : 770 - 770